Upregulation of TrkB Promotes Epithelial-Mesenchymal Transition and Anoikis Resistance in Endometrial Carcinoma

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Bao, Wei ^a   Qiu, Haifeng ^b   Yang, Tingting ^b   Luo, Xin ^a   Zhang, Huijuan ^a   Wan, Xiaoping ^b  

^a Shanghai Municipal Key Clinical Specialty Shanghai Jiao Tong University School of Medicine   (China)

^b SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; REGULATOR PROTEIN; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR TWIST;

ADULT; ANOIKIS; ARTICLE; CANCER CELL CULTURE; CANCER PROGNOSIS; CANCER RESISTANCE; CELL MIGRATION; CELL SUSPENSION; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; ENZYME BLOOD LEVEL; ENZYME REGULATION; ENZYME RELEASE; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; MEDIATOR; PERITONEUM METASTASIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; RECEPTOR DOWN REGULATION; RNA INTERFERENCE; TUMOR INVASION;

ADULT; AGED; ANIMALS; ANOIKIS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; ENDOMETRIAL NEOPLASMS; ENZYME ACTIVATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; RECEPTOR, TRKB; TUMOR BURDEN; TUMOR CELLS, CULTURED; TWIST TRANSCRIPTION FACTOR;

EID: 84880840836     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070616     Document Type: Article

References (47)

1. Siegel R, Naishadham D, Jemal A, (2013) Cancer statistics, 2013. CA Cancer J Clin 63: 11-30.
2. Salvesen HB, Haldorsen IS, Trovik J, (2012) Markers for individualised therapy in endometrial carcinoma. Lancet Oncol 13: e353-361.
3. Sorosky JI, (2012) Endometrial cancer. Obstet Gynecol 120: 383-397.
4. Vale CL, Tierney J, Bull SJ, Symonds PR, (2012) Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma. Cochrane Database Syst Rev 8: CD003915.
5. Brodeur GM, Minturn JE, Ho R, Simpson AM, Iyer R, et al. (2009) Trk receptor expression and inhibition in neuroblastomas. Clin Cancer Res 15: 3244-3250.
6. Harada T, Yatabe Y, Takeshita M, Koga T, Yano T, et al. (2011) Role and relevance of TrkB mutations and expression in non-small cell lung cancer. Clin Cancer Res 17: 2638-2645.
7. Vanhecke E, Adriaenssens E, Verbeke S, Meignan S, Germain E, et al. (2011) Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival. Clin Cancer Res 17: 1741-1752.
8. Sclabas GM, Fujioka S, Schmidt C, Li Z, Frederick WA, et al. (2005) Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells. Clin Cancer Res 11: 440-449.
9. Zhang Y, Fujiwara Y, Doki Y, Takiguchi S, Yasuda T, et al. (2008) Overexpression of tyrosine kinase B protein as a predictor for distant metastases and prognosis in gastric carcinoma. Oncology 75: 17-26.
10. Yu Y, Zhang S, Wang X, Yang Z, Ou G, (2010) Overexpression of TrkB promotes the progression of colon cancer. Apmis 118: 188-195.
11. Bronzetti E, Artico M, Forte F, Pagliarella G, Felici LM, et al. (2008) A possible role of BDNF in prostate cancer detection. Oncol Rep 19: 969-974.
12. Yu X, Liu L, Cai B, He Y, Wan X, (2008) Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer. Cancer Sci 99: 543-552.
13. Pearse RN, Swendeman SL, Li Y, Rafii D, Hempstead BL, (2005) A neurotrophin axis in myeloma: TrkB and BDNF promote tumor-cell survival. Blood 105: 4429-4436.
14. Nakamura K, Martin KC, Jackson JK, Beppu K, Woo CW, et al. (2006) Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells. Cancer Res 66: 4249-4255.
15. Martens LK, Kirschner KM, Warnecke C, Scholz H, (2007) Hypoxia-inducible factor-1 (HIF-1) is a transcriptional activator of the TrkB neurotrophin receptor gene. J Biol Chem 282: 14379-14388.
16. Lee J, Jiffar T, Kupferman ME, (2012) A novel role for BDNF-TrkB in the regulation of chemotherapy resistance in head and neck squamous cell carcinoma. PLoS One 7: e30246.
17. Douma S, Van Laar T, Zevenhoven J, Meuwissen R, Van Garderen E, et al. (2004) Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature 430: 1034-1039.
18. Thiery JP, (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454.
19. Bahng AY, Chu C, Wileyto P, Rubin S, Lin LL, (2012) Risk factors for recurrence amongst high intermediate risk patients with endometrioid adenocarcinoma. J Gynecol Oncol 23: 257-264.
20. Colas E, Pedrola N, Devis L, Ertekin T, Campoy I, et al. (2012) The EMT signaling pathways in endometrial carcinoma. Clin Transl Oncol 14: 715-720.
21. Creasman W, (2009) Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet 105: 109.
22. Kyo S, Sakaguchi J, Ohno S, Mizumoto Y, Maida Y, et al. (2006) High Twist expression is involved in infiltrative endometrial cancer and affects patient survival. Hum Pathol 37: 431-438.
23. Au CW, Siu MK, Liao X, Wong ES, Ngan HY, et al. (2009) Tyrosine kinase B receptor and BDNF expression in ovarian cancers- Effect on cell migration, angiogenesis and clinical outcome. Cancer Lett 281: 151-161.
24. Thompson CC, Ashcroft FJ, Patel S, Saraga G, Vimalachandran D, et al. (2007) Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motility. Gut 56: 95-106.
25. Smit MA, Geiger TR, Song JY, Gitelman I, Peeper DS, (2009) A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis. Mol Cell Biol 29: 3722-3737.
26. Smit MA, Peeper DS, (2011) Zeb1 is required for TrkB-induced epithelial-mesenchymal transition, anoikis resistance and metastasis. Oncogene 30: 3735-3744.
27. Huber MA, Kraut N, Beug H, (2005) Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17: 548-558.
28. Jaboin J, Kim CJ, Kaplan DR, Thiele CJ, (2002) Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway. Cancer Res 62: 6756-6763.
29. Schramm A, Schulte JH, Astrahantseff K, Apostolov O, Limpt V, et al. (2005) Biological effects of TrkA and TrkB receptor signaling in neuroblastoma. Cancer Lett 228: 143-153.
30. Thiele CJ, Li Z, McKee AE, (2009) On Trk-the TrkB signal transduction pathway is an increasingly important target in cancer biology. Clin Cancer Res 15: 5962-5967.
31. Anger DL, Zhang B, Boutross-Tadross O, Foster WG, (2007) Tyrosine receptor kinase B (TrkB) protein expression in the human endometrium. Endocrine 31: 167-173.
32. Okamura K, Harada T, Wang S, Ijichi K, Furuyama K, et al. (2012) Expression of TrkB and BDNF is associated with poor prognosis in non-small cell lung cancer. Lung Cancer 78: 100-106.
33. de Farias CB, Heinen TE, dos Santos RP, Abujamra AL, Schwartsmann G, et al. (2012) BDNF/TrkB signaling protects HT-29 human colon cancer cells from EGFR inhibition. Biochem Biophys Res Commun 425: 328-332.
34. Tanaka K, Mohri Y, Nishioka J, Kobayashi M, Ohi M, et al. (2009) Neurotrophic receptor, tropomyosin-related kinase B as an independent prognostic marker in gastric cancer patients. J Surg Oncol 99: 307-310.
35. Odate S, Nakamura K, Onishi H, Kojima M, Uchiyama A, et al. (2013) TrkB/BDNF signaling pathway is a potential therapeutic target for pulmonary large cell neuroendocrine carcinoma. Lung Cancer 79: 205-214.
36. Sasahira T, Ueda N, Kurihara M, Matsushima S, Ohmori H, et al. (2013) Tropomyosin receptor kinases B and C are tumor progressive and metastatic marker in colorectal carcinoma. Hum Pathol.
37. Geiger TR, Peeper DS, (2005) The neurotrophic receptor TrkB in anoikis resistance and metastasis: a perspective. Cancer Res 65: 7033-7036.
38. Simpson CD, Anyiwe K, Schimmer AD, (2008) Anoikis resistance and tumor metastasis. Cancer Lett 272: 177-185.
39. Liu Z, Li H, Derouet M, Berezkin A, Sasazuki T, et al. (2006) Oncogenic Ras inhibits anoikis of intestinal epithelial cells by preventing the release of a mitochondrial pro-apoptotic protein Omi/HtrA2 into the cytoplasm. J Biol Chem 281: 14738-14747.
40. Geiger TR, Peeper DS, (2007) Critical role for TrkB kinase function in anoikis suppression, tumorigenesis, and metastasis. Cancer Res 67: 6221-6229.
41. Frisch SM, Schaller M, Cieply B, (2013) Mechanisms that link the oncogenic epithelial-mesenchymal transition to suppression of anoikis. J Cell Sci 126: 21-29.
42. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, et al. (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927-939.
43. Tiwari N, Gheldof A, Tatari M, Christofori G, (2012) EMT as the ultimate survival mechanism of cancer cells. Semin Cancer Biol 22: 194-207.
44. Yoshii A, Constantine-Paton M, (2010) Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease. Dev Neurobiol 70: 304-322.
45. Huang YZ, McNamara JO, (2010) Mutual regulation of Src family kinases and the neurotrophin receptor TrkB. J Biol Chem 285: 8207-8217.
46. Roesler R, de Farias CB, Abujamra AL, Brunetto AL, Schwartsmann G, (2011) BDNF/TrkB signaling as an anti-tumor target. Expert Rev Anticancer Ther 11: 1473-1475.
47. Makino K, Kawamura K, Sato W, Kawamura N, Fujimoto T, et al. (2012) Inhibition of uterine sarcoma cell growth through suppression of endogenous tyrosine kinase B signaling. PLoS One 7: e41049.